Informed Health 2016
The Right Information @ The Right Time =
The Right Outcome
In most areas of our lives data is being utilized to optimize the consumer experience in ways that result in achieving an optimal outcome. In medicine this has historically been the exception but that is rapidly changing. From meeting the challenges of data interoperability, point of care decision-making to managing patient privacy and regulatory requiements, Informed Health 2016 will feature galvanizing conversations, and insightful discussions about achieving breakthrough innovation in getting the right information at the right time in order to achieve the right outcome. We call that Informed Health.
2016 Informed Health Speakers
Andrew Auerbach, MD
Dr. Auerbach is Professor in Residence and Director of Research for the Division of Hospital Medicine at UCSF, Director of Clinical Content for UCSF’s electronic health record (Apex), Editor in Chief of the Journal of Hospital Medicine, and leads validation efforts for the CDHI.
Dr. Auerbach leads a number of clinical improvement and research programs at UCSF, including efforts focused on medication reconciliation, patient-centered outcomes measurement in common inpatient diseases, patient-engagement in care transitions, and quality measurement efforts.
Michael Blum, MD
Dr. Michael Blum is the Associate Vice Chancellor for Informatics and a Professor of Medicine in Cardiology at UCSF. As an active clinician, Dr. Blum is passionate about wellness and prevention of heart disease through lifestyle.
Prior to his medical career, Dr. Blum was trained as an engineer, and he applies his expertise in technology to health care as UCSF’s Chief Medical Information Officer and Director of the Center for Digital Health Innovation at UCSF which develops and evaluates novel digital health applications, devices, sensors, and platforms in pursuit of Precision Medicine. He led the successful enterprise-wide deployment of Epic’s electronic health record as well as enterprise data warehousing at UCSF.
Dr. Blum has been involved with numerous start-ups and early stage companies and serves as the founding Director of the UCSF-Samsung Digital Health Innovation Lab.
Regis B. Kelly, PhD - place holder
Dr. Regis B. Kelly is the Director of one of four California Institutes for Science and Innovation, created by the California Legislature to strengthen the academic foundation of its technology-based industries. QB3 is the only one of the four devoted exclusively to biology and to the life science industries. It is an innovation center made up of over 200 quantitative biologists at three northern California campuses (UCB, UCSC & UCSF) converting its discoveries into practical benefits for society.
From 2000 to 2004, Dr. Kelly served as Executive Vice Chancellor at the University of California in San Francisco, where his major responsibility was the new Mission Bay campus. This campus is the center of academic planning for a 300 acre public/private biomedical research park in San Francisco.
From 1995 to 2000, Dr. Kelly served as Chair of the Department of Biochemistry and Biophysics at UCSF; from 1988 to 1995, he was the Director of UCSF’s Cell Biology Graduate Program; and from 1992 to 2000, he was the Director of the Hormone Research Institute at UCSF. He has published extensively in the areas of cell and neurobiology and remains a Professor Emeritus of the Department of Biochemistry and Biophysics.
Dr. Kelly received his undergraduate degree in Physics from the University of Edinburgh in Scotland in 1961 and his Ph.D. in Biophysics from the California Institute of Technology in 1967. Following a post-doctoral fellowship at Stanford, Dr. Kelly was an instructor in the Department of Neurobiology at Harvard. He is Chairman Emeritus of the Bay Area Scientific Innovation Consortium (BASIC), is on the Malaysian Prime Minister’s Biotechnology Advisory Panel, and is on the Boards of the California Foundation for Molecular Biology, and the ChinaSF Program, among others. He is also a General Partner of Mission Bay Capital venture fund.
In 2011, Dr. Kelly was inducted into the Bay Area Business Hall of Fame. He is a fellow of the American Academy of Arts and Sciences, and has received an OBE from the British Government.
Courtney Lyles, PhD -place holder
Courtney Lyles, PhD, is an Assistant Professor in the UCSF Division of General Internal Medicine at San Francisco General Hospital and the UCSF Center for Vulnerable Populations.
A trained health services researcher, she uses quantitative and qualitative methods to examine quality of care, health behavior, and health outcomes. Her research focuses on harnessing health information technology to improve patient-provider communication for chronic disease self-management to ultimately reduce disparities in health and healthcare outcomes.
She is currently on a career development award from the Agency for Healthcare Research and Quality to engage patients in using online patient portals for healthcare management, including leveraging user-centered design and implementation principles to create as well as spread technologies that are relevant for diverse patient populations.
Aenor Sawyer, MD
Dr. Sawyer has more than a decade of Health Technology experience including Telemedicine, EMR design and implementation, and development of device and digital health solutions. As the Associate Director of Strategic Relations in the UCSF Center for Digital Health Innovation and the Associate Director of the Digital Health track in the CTSI Catalyst accelerator, she guides the development of new technologies and their “frontline innovators.” Dr. Sawyer guides development, evaluation and translation of novel technologies at UCSF and also at external incubators. She also is a member of the UCSF Telemedicine Committee and Chairs the New Technology Committee in the Department of Orthopaedic Surgery.
A ‘frontline innovator’ herself, she co-founded (with Pierre Theodore) Trinity, a HIPAA secure, online, virtual Tumor Board asnd multidisciplinary collaboration technology. Trinity allows specialists from different disciplines, at different locations and on different schedules to view pertinent patient data, exchange expertise and rapidly form optimal diagnostic and treatment decisions. In the device arena she serves as Project Director (Roboimplant) in the Pediatric Device Consortium and is an advisory member of the Surgical Innovation Committee and the Center for Disruptive Musculoskeletal Innovation. With a focus on fall prevention, she co-developed a safe early-mobility device (MOBI-US), combining DME, Sensor and Digital technologies. Beyond UCSF, she is an advisor at Rock Health and Epocrates, and is a member of the NIH CTSA Telemedicine/Telehealth TSIG. Dr. Sawyer is also on the External Advisory Board for Scripps Institute CTSA.
As a practicing clinician Dr. Sawyer is an Assistant Clinical Professor in the UCSF Department of Orthopaedic Surgery, where she combines a background in Orthopaedics, Physical Therapy, Exercise Physiology and Health Technology to provide comprehensive musculoskeletal care. She is Director of the multidisciplinary UCSF Skeletal Health Service empowering Pediatric to Geriatric patients to optimize their bone health across the lifespan.
She is also the Medical Officer for the Great Pacific Race and worldwide transoceanic rowers, a role in which she leverages a variety of remote communications and sensing technologies.
Dr Sawyer completed her MS and MD at UC Davis, her Orthopaedic Surgery Residency at Stanford and her Fellowships in the Harvard Combined Orthopaedic Surgery and Boston Childrens Hospital.
Rhona is responsible for building relationships, bringing the team together and executing on CDHI’s strategic vision and operations.
Prior to joining CDHI, Rhona was responsible for overseeing product development and business strategy for UCSF School of Medicine IT, which included planning the early-stage adoption of innovation programs such as Telemedicine and SalesForce.
Rhona earned an honors BS in Computer Science at UCC, Ireland.
Keith R. Yamamoto, PhD
Dr. Keith Yamamoto obtained his PhD from Princeton University. He is currently Vice Chancellor for Research, Executive Vice Dean of the School of Medicine, and Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco.
Throughout his career, Dr. Yamamoto’s research has focused on signaling and transcriptional regulation by nuclear receptors; he uses structural, mechanistic and systems approaches to pursue these problems in pure molecules, cells and whole organisms.
Dr. Yamamoto has led or served on numerous national committees focused on public and scientific policy, public understanding and support of biological research, and science education; he chairs the Coalition for the Life Sciences, and he serves on the Advisory Committee for Division of Earth and Life Studies for the National Academy of Sciences, following six years as chair of the Board on Life Sciences within that division. Dr. Yamamoto has chaired or served on many committees that oversee the process of peer review and the policies that govern it at the National Institutes of Health; he recently completed a three-year appointment on the Advisory Council of the NIH Center for Scientific Review. He chairs the External Advisory Committee for the Watson School of Biological Sciences at the Cold Spring Harbor Laboratory, serves as a member of the advisory boards for Research!America and Lawrence Berkeley National Laboratory and sits on the Council of the Institute of Medicine. Dr. Yamamoto is an elected member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and the American Academy of Microbiology, and is a fellow of the American Association for the Advancement of Science